Connect your AI

Denali Therapeutics Inc. DNLI Price / sales

Price / sales at other companies

Eli LillyLLY

11.4×-3.8×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Acadia PharmaceuticalsACAD

3.5×+0.7×

BridgeBio PharmaBBIO

24.8×-26.8×

BiogenBIIB

2.7×+0.7×

PTC TherapeuticsPTCT

6.8×+4.6×

Other financials

Income statement

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

Market cap$3.7B+54.2%

Enterprise value$3.35B+37.1%

Profitability

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

market cap/total revenue=2,613.6×

Based on the most recent quarter.

The official record: Denali Therapeutics Inc.’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Denali Therapeutics Inc.'s price / sales?: Denali Therapeutics Inc. (DNLI) reported price / sales of 2,613.6× in Q2 2024.
How has Denali Therapeutics Inc.'s price / sales changed year-over-year?: Denali Therapeutics Inc.'s price / sales increased by 22098.5% year-over-year, from 11.8× to 2,613.6×.
What is the long-term trend for Denali Therapeutics Inc.'s price / sales?: Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s price / sales has grown at a -33.5% compound annual growth rate (CAGR), from 30.5× to 9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.